Cargando…

Cyclin kinase inhibitors and interferons in lupus

Detalles Bibliográficos
Autor principal:	Theofilopoulos, A
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2003
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833816/ http://dx.doi.org/10.1186/ar826

Ejemplares similares

A genetic analysis of lupus
por: Theofilopoulos, AN
Publicado: (2004)

Tracing cellular sources of pathogenic type I-interferon in the TREX1(-/-) mouse model of lupus like-disease
por: Peschke, K, et al.
Publicado: (2015)

Insights into the activation of transcription elongation by lentiviruses: structure of the Cyclin T1-Tat-TAR RNA complex
por: Anand, Kanchan, et al.
Publicado: (2009)

Prevalence and demographics of systemic lupus erythematosus and lupus nephritis among US children with Medicaid coverage, 2002-2004
por: Hiraki, Linda T, et al.
Publicado: (2012)

Analysis of B-cell subpopulations in systemic lupus erythematosus
por: Dorner, T, et al.
Publicado: (2003)

Natural Treg and role of IL-2 in lupus
por: Riemekasten, Gabriela, et al.
Publicado: (2011)

Autoantibodies and cognitive impairment in systemic lupus erythematosus
por: Kowal, C, et al.
Publicado: (2004)

Epidemiology of foot complaints in systemic lupus erythematosus
por: Otter, S, et al.
Publicado: (2015)

Differentially expressed genes responsible for insensitivity of CD34+ cells to kinase inhibitors in patients with chronic myeloid leukemia
por: Moreira-Nunes, Caroline FA, et al.
Publicado: (2013)

Familial chilblain lupus caused by an activating mutation in STING
por: König, N, et al.
Publicado: (2015)

Defective removal of ribonucleotides from DNA promotes systemic lupus erythematosus
por: Günther, C, et al.
Publicado: (2015)

Interferons and IRF/Stat transcription factors in the regulation of immunity, oncogenesis and bone remodeling
por: Taniguchi, T, et al.
Publicado: (2003)

Neratinib, an irreversible pan erB receptor tyrosine kinase inhibitor active for advanced HER2(+ )breast cancer
por: Cortés-Funes, H, et al.
Publicado: (2009)

Subclinical cardiovascular abnormalities in patients with juvenile systemic lupus erythematosus
por: Canpolat, Nur, et al.
Publicado: (2011)

Viral myocarditis vs lupus myocarditis, distinctive features in Cardiovascular Magnetic Resonance
por: Barillas, Maria A Espinoza
Publicado: (2016)

Origins of systemic lupus erythematosus: genes, environment, and host immune response
por: Harley, JB, et al.
Publicado: (2003)

Clinical phenotype of neonatal lupus erythematosus relates to autoantibody level and gender
por: Venkatesan, S, et al.
Publicado: (2011)

Analysis of growth in female patients with pediatric-onset systemic lupus erythematosus
por: Mak, NC, et al.
Publicado: (2011)

Antibody-initiated organ injury: apoptosis, inflammation and fibrosis in neonatal lupus
por: Buyon, JP, et al.
Publicado: (2004)

10. Drug-induced lupus as a trigger for macrophage activation syndrome
por: Leith, Mark, et al.
Publicado: (2019)

14.2 Causes of early death in juvenile onset systemic lupus erythematosus (JSLE)
por: Bader-Meunier, B, et al.
Publicado: (2008)

Haematological and molecular responses in patients with chronic ATLL treated with zidovudine and interferon-α
por: Hodson, Andrew, et al.
Publicado: (2014)

Failure of receptor revision in the autoreactive B cells in patients with systemic lupus erythematosus
por: Yoshikawa, H, et al.
Publicado: (2003)

Long-term education and employment outcomes in pediatric-onset systemic lupus erythematosus
por: Lawson, Erica F, et al.
Publicado: (2012)

Foot problems in patients with systemic lupus erythematosus; under-reported and under-treated?
por: Otter, S, et al.
Publicado: (2015)

Neutralization of Interferon-gamma is efficacious in a mouse model of HLH secondary to chronic inflammation
por: Prencipe, G, et al.
Publicado: (2015)

Follow up study of B-lymphocyte depletion in the treatment of patients with systemic lupus erythematosus
por: Leandro, MJ, et al.
Publicado: (2005)

Insights into systemic lupus erythematosus pathogenesis through blood global gene expression analysis
por: Pascual, V, et al.
Publicado: (2004)

OA19 A case of severe refractory lupus enteritis and nephritis that remitted with Obinutuzumab
por: Chakravorty, Mithun, et al.
Publicado: (2022)

Partial inhibition of HIV replication by type-I interferons: impact of cell-to-cell viral transfer
por: Vendrame, Daniela, et al.
Publicado: (2009)

Interferon gamma (IFNg) drives disease in the TLR9-mediated cytokine storm syndrome in mice
por: de Min, C, et al.
Publicado: (2015)

Deficiency of the Cyclin Kinase Inhibitor p21(WAF-1/CIP-1) Promotes Apoptosis of Activated/Memory T Cells and Inhibits Spontaneous Systemic Autoimmunity
por: Lawson, Brian R., et al.
Publicado: (2004)

Myocardial tissue characterisation with late gadolinium enhancement in rheumatoid arthritis, systemic lupus erythematosus and systemic sclerosis
por: Ntusi, Ntobeko A, et al.
Publicado: (2013)

Interferon-β sensitizes human glioblastoma cells to the cyclin-dependent kinase inhibitor, TG02
por: Lohmann, Birthe, et al.
Publicado: (2020)

PI 3-kinase and disease
por: Cantley, Lewis C
Publicado: (2012)

PI 3-kinase and disease
por: Cantley, Lewis C
Publicado: (2014)

Defining clinical remission and clinically inactive disease in juvenile systemic lupus erythematosus (jSLE)
por: Mina, Rina, et al.
Publicado: (2011)

9.4 Autoantibodies in pediatric systemic lupus erythematosus: ethnic grouping, autoantibody clustering and clinical correlations
por: Jurencak, R, et al.
Publicado: (2008)

PD-L1 expression on monocytes marks active systemic lupus erythematosus in patients without nephritis
por: Stevens, Anne M, et al.
Publicado: (2012)

Native T1 mapping by cardiovascular resonance imaging detects subclinical cardiomyopathy in patients with systemic lupus erythematosus
por: Puntmann, Valentina O, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_de6e324p95nle43hsl6pgnfd81